Tina Manning talks about her experience of being diagnosed with malignant melanoma and treated with pembrolizumab.
Patient advocate Cara Hoofe describes her experiences of being out of active treatment following treatment for colorectal cancer.
Dr Sebastian Guettler talks us through the new chromatography machine, purchased using generous donations from ICR supporters.
Find out more about the ICR’s Will for Free programme – who can use it, how it works, and the life-changing impact you can have on the future of cancer research.
A drug used in treating non-small cell lung cancer could offer a new targeted therapy for thousands of breast cancer patients following the discovery that it can kill breast cancer cells with a particular genetic defect.
Agnes Steed talks about her experience of having ovarian cancer and the importance of more research.
Dr Olivia Rossanese, is finding new ways to target cancer using precision medicine as an alternative strategy to some of the one-size-fits-all approaches of older cancer treatments.
Dr Sadanandam’s team is working on a number of projects that they are keen to develop in collaboration with commercial partners.
Dr Paul Huang's Protein Networks team is keen to collaborate with industry partners on a number of projects on biochemistry, computational modelling, molecular pathology and proteomics.